CEP-37440

Generic Name: CEP-37440

Brand Names: -

Drug Type: Small Molecule

Chemical Formula: C_₃₀H_₃₈ClN_₇O_₃

CAS Number: 1391712-60-9

Unique Ingredient Identifier: O3MNS8782H

Background: CEP-37440 has been used in trials studying the treatment of Solid Tumors.

Associated Conditions: -

Associated Therapies: -

Clinical Trials

To Determine the Maximum Tolerated Dose of Oral CEP-37440 in Patients With Advanced or Metastatic Solid Tumors

Phase 1

Completed

Conditions: Solid Tumors

Interventions: Drug: CEP-37440

First Posted Date: 2013-08-14

Last Posted Date: 2021-11-12

Lead Sponsor: Teva Branded Pharmaceutical Products R&D, Inc.

Target Recruit Count: 32

Registration Number: NCT01922752

Locations: 🇺🇸
Teva Investigational Site 10686, San Antonio, Texas, United States
🇺🇸
Teva Investigational Site 10689, Chicago, Illinois, United States
🇺🇸
Teva Investigational Site 10687, Philadelphia, Pennsylvania, United States

Prev
1
Next

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy